Activity Survey

The APBMT Activity Survey has been performed since 2007.
The following figure shows how the data was collected.

Data collection.jpg

The way of submission is different in each country/region.
From the countries/regions which have a national registry, data is submitted through the national registries. From the countries/regions which do not have a national registry, data is submitted through the regional persons in charge who collect data from major transplant centers or through major transplant centers directly.

AS for 2014.png

The result of Activity Survey 2017(HSCT performed in 2015)

スライド3.PNG

The No. of HSCTs are increasing year by year.

In 2015, that exceeded seventeen-thousand in Asia- Pacific region.

スライド4.PNG

18 countries and six-handred-twenty-one centers cooperated with our Activity Survey.

We appreciate about 40 cooperators made effort collecting this survey.

スライド16.PNG

Following trends of Unrelated donor source.

The percentage of Peripheral blood and Cord Blood is increasing year by year.

Meanwhile, Bone Marrow is decreasing and was getting less than 30% in 2015.

The percentage of Mixture source is less than 1%.

スライド5.PNG

In 2015, Australia:1723, Bangladesh:8, China:4052, HongKong:139, India:1636, Iran:438, Japan:5609, Korea:2286, Malaysia:401, Myanmar:2, NewZealand:260, Pakistan:2, Philippines:28, Singapore:182, SriLanka:9, Taiwan:521, Thailand:57, Vietnam:78 HSCTs performed.

スライド7.PNG

*Detailed of countries that no,of HSCT were under 1000 in 2015:Bangladesh, HongKong, Iran, Malaysia, Myanmar, NewZealand, Pakistan, Philippines, Singapore, SriLanka, Taiwan, Thailand, and Vietnam.

スライド10.PNG

The pie chart showing the Main indication of HSCTs in Asia-Pacific area.

AML accounts for more than 20 percent, Lymphoid malignancy: 20%, Plasma Cell Disorder: 18%, and  ALL : 13%. These top 4 indication accounts three fourth of the whole.

スライド22.PNG

0.1-100     Bangladesh, China, India, Myanmar, Pakistan, Philippines,

                  Sri Lanka, Thailand, and Vietnam

100-300    Hong Kong, Iran, Malaysia, and Taiwan

300-500    South Korea, Singapore, and Japan

more than 500    Australia, and New Zealand